About theTranslational Research Program
This program aims to initiate and maintain multidisciplinary research projects in the area of cancer pharmacogenomics and pharmacokinetics with emphasis on the effects on patient's outcomes.
Multidisciplinary research teams
The program works with all stakeholders to promote the formation of multidisciplinary research teams investigating predictors of patients' outcomes through translational research projects examining genetic and pharmacokinetic variability among patients and aiming towards personalized cancer medicine.
National, regional, and international collaborations
Collaborations in translational research and personalized medicine are being established in order to facilitate the implementation of these concepts in health management and clinical decision-making.